Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis

The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mor...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 17; no. 11; p. e0276774
Main Authors Uruma, Yuka, Manabe, Toshie, Fujikura, Yuji, Iikura, Motoyasu, Hojo, Masayuki, Kudo, Koichiro
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.11.2022
Public Library of Science (PLoS)
Subjects
Asthma
Asthma - epidemiology
Chronic obstructive pulmonary disease
Cohort analysis
Comorbidity
Complications and side effects
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - mortality
COVID-19 - therapy
Health risks
Humans
Lung diseases
Lung diseases, Obstructive
Medicine and Health Sciences
Meta-analysis
Mortality
Mortality risk
Obstructive lung disease
Patients
People and Places
Physical Sciences
Prevalence
Pulmonary Disease, Chronic Obstructive - epidemiology
Research and Analysis Methods
Risk Assessment
Japan
Netherlands
United Kingdom > UK
United States > US
China
Online AccessGet full text

Cover

Abstract The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis. We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country. One hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79-11.30), 8.18% (95% CI, 7.01-9.35), and 3.70% (95% CI, 2.40-5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55-1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74-5.24; p<0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India. Pre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.
AbstractList Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis. Methods We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country. Results One hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79-11.30), 8.18% (95% CI, 7.01-9.35), and 3.70% (95% CI, 2.40-5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55-1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74-5.24; p<0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India. Conclusion Pre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.
The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis. We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country. One hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79-11.30), 8.18% (95% CI, 7.01-9.35), and 3.70% (95% CI, 2.40-5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55-1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74-5.24; p<0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India. Pre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.
The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis. We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country. One hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79-11.30), 8.18% (95% CI, 7.01-9.35), and 3.70% (95% CI, 2.40-5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55-1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74-5.24; p<0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India. Pre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.
Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis. Methods We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country. Results One hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79–11.30), 8.18% (95% CI, 7.01–9.35), and 3.70% (95% CI, 2.40–5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55–1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74–5.24; p <0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India. Conclusion Pre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.
The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis.INTRODUCTIONThe prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks of mortality. The present study aimed to assess the prevalence of asthma, COPD, and ACO as comorbidities, and to determine their risks of mortality in patients with COVID-19 using a systematic review and meta-analysis.We systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country.METHODSWe systematically reviewed clinical studies that reported the comorbidities of asthma, COPD, and ACO in patients with COVID-19. We searched various databases including PubMed (from inception to 27 September 2021) for eligible studies written in English. A meta-analysis was performed using the random-effect model for measuring the prevalence of asthma, COPD, and ACO as comorbidities, and the mortality risk of asthma, COPD, and ACO in patients with COVID-19 was estimated. A stratified analysis was conducted according to country.One hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79-11.30), 8.18% (95% CI, 7.01-9.35), and 3.70% (95% CI, 2.40-5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55-1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74-5.24; p<0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India.RESULTSOne hundred one studies were eligible, and 1,229,434 patients with COVID-19 were identified. Among them, the estimated prevalence of asthma, COPD, and ACO using a meta-analysis was 10.04% (95% confidence interval [CI], 8.79-11.30), 8.18% (95% CI, 7.01-9.35), and 3.70% (95% CI, 2.40-5.00), respectively. The odds ratio for mortality of pre-existing asthma in COVID-19 patients was 0.89 (95% CI, 0.55-1.4; p = 0.630), while that in pre-existing COPD in COVID-19 patients was 3.79 (95% CI, 2.74-5.24; p<0.001). France showed the highest prevalence of asthma followed by the UK, while that of COPD was highest in the Netherlands followed by India.Pre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.CONCLUSIONPre-existing asthma and COPD are associated with the incidence of COVID-19. Having COPD significantly increases the risk of mortality in patients with COVID-19. These differences appear to be influenced by the difference of locations of disease pathophysiology and by the daily diagnosis and treatment policy of each country.
Audience Academic
Author Kudo, Koichiro
Manabe, Toshie
Uruma, Yuka
Iikura, Motoyasu
Hojo, Masayuki
Fujikura, Yuji
AuthorAffiliation 1 Nagoya City University Medical School, Aichi, Japan
3 Nagoya City University West Medical Center, Aichi, Japan
8 Waseda University, Institute for Asia Human Community, Tokyo, Japan
5 Department of Medical Risk Management and Infection Control, National Defense Medical College Hospital, Tokorozawa, Japan
7 Yurin Hospital, Tokyo, Japan
2 Nagoya City University Graduate School of Medical Sciences, Aichi, Japan
4 Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Saitama, Japan
6 Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
Kyung Hee University School of Medicine, REPUBLIC OF KOREA
AuthorAffiliation_xml – name: 3 Nagoya City University West Medical Center, Aichi, Japan
– name: 4 Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Saitama, Japan
– name: 7 Yurin Hospital, Tokyo, Japan
– name: 8 Waseda University, Institute for Asia Human Community, Tokyo, Japan
– name: 6 Department of Respiratory Medicine, National Center for Global Health and Medicine, Tokyo, Japan
– name: 5 Department of Medical Risk Management and Infection Control, National Defense Medical College Hospital, Tokorozawa, Japan
– name: 1 Nagoya City University Medical School, Aichi, Japan
– name: Kyung Hee University School of Medicine, REPUBLIC OF KOREA
– name: 2 Nagoya City University Graduate School of Medical Sciences, Aichi, Japan
Author_xml – sequence: 1
  givenname: Yuka
  surname: Uruma
  fullname: Uruma, Yuka
– sequence: 2
  givenname: Toshie
  orcidid: 0000-0002-8208-8071
  surname: Manabe
  fullname: Manabe, Toshie
– sequence: 3
  givenname: Yuji
  surname: Fujikura
  fullname: Fujikura, Yuji
– sequence: 4
  givenname: Motoyasu
  surname: Iikura
  fullname: Iikura, Motoyasu
– sequence: 5
  givenname: Masayuki
  orcidid: 0000-0002-9595-9657
  surname: Hojo
  fullname: Hojo, Masayuki
– sequence: 6
  givenname: Koichiro
  surname: Kudo
  fullname: Kudo, Koichiro
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36318528$$D View this record in MEDLINE/PubMed
BookMark eNqNk21v0zAQxyM0xB7gGyCIhIRAWkr8EDvZC6SqG1BpUtGAvbWujt26SuISO4N-e5w1Re00IeQXsS6_-9_dX77T6KixjYqilygdIcLRh5Xt2gaq0TqERynmjHP6JDpBBcEJwyk52rsfR6fOrdI0Izljz6JjwgjKM5yfRDdXWivpY6tjcH5Zw3k8mX29PI-hKePxZBbbJgRup5cJKi7icew2zqsavJFxq-6M-nUP1spDAqGbjTPuefRUQ-XUi-F7Fv34dPV98iW5nn2eTsbXieRZ7hOWpbxgnGnGtCpx6ELPqVbzUkvCqOaYlhzKlOBsnhe0JCxnmaaUMQW4YAyRs-j1VnddWScGO5zAnKCU0CyjgZhuidLCSqxbU0O7ERaMuA_YdiGgDaNUSiAscyChs4JSGoyCvjDBeVFkJRQIB62PQ7VuXqtSqsa3UB2IHv5pzFIs7J0oGKYU9wLvBoHW_uyU86I2TqqqgkbZbug7Y3meB_TNA_Tx6QZqAWEA02gb6speVIyDe5ynPCWBGj1ChVOq2sjwdrQJ8YOE9wcJgfHqt19A55yYfrv5f3Z2e8i-3WOXCiq_dLbqvLGNOwRf7Tv91-Ldow3AxRaQrXWuVVpI46HXCaOZSqBU9BuyM030GyKGDQnJ9EHyTv-faX8AT2kPgA
CitedBy_id crossref_primary_10_3390_vaccines12040414
crossref_primary_10_1016_j_jaip_2024_05_025
crossref_primary_10_1016_S2468_2667_23_00079_8
crossref_primary_10_1038_s41598_024_64670_9
crossref_primary_10_1016_j_intimp_2023_110365
crossref_primary_10_1016_j_puhe_2023_10_040
crossref_primary_10_1155_2024_1595091
crossref_primary_10_3390_jcm14051446
crossref_primary_10_1016_j_rmed_2024_107635
crossref_primary_10_3390_jcm12030928
crossref_primary_10_1007_s44197_024_00298_2
crossref_primary_10_1186_s40001_024_01718_6
crossref_primary_10_3390_clinpract13060124
crossref_primary_10_1513_AnnalsATS_202311_974OC
crossref_primary_10_1371_journal_pone_0316553
crossref_primary_10_3390_vaccines11081392
Cites_doi 10.1111/cea.13997
10.1016/j.chest.2020.05.575
10.1001/jama.283.15.2008
10.1159/000486797
10.1016/j.jaip.2020.09.050
10.1183/13993003.01875-2020
10.1038/s41598-021-88111-z
10.1371/journal.pone.0249920
10.3906/sag-2006-164
10.1159/000510953
10.1016/j.jinf.2020.09.033
10.4081/monaldi.2020.1568
10.4187/respcare.08631
10.1016/j.rmed.2020.106205
10.1016/j.jaip.2020.09.044
10.1016/j.chest.2018.10.044
10.1136/bmj.327.7414.557
10.1111/aas.13785
10.1111/all.14517
10.1186/s41256-021-00210-6
10.1111/jce.14772
10.1016/j.ajog.2020.05.031
10.1016/j.anai.2021.02.020
10.1016/j.jaip.2020.06.032
10.1371/journal.pone.0254875
10.3389/fimmu.2021.668074
10.1016/j.anai.2020.07.029
10.1016/j.ijcard.2020.09.001
10.1371/journal.pone.0246586
10.1016/S2213-2600(20)30415-X
10.1002/jmv.27123
10.2147/COPD.S312493
10.1371/journal.pone.0236618
10.1016/j.jaip.2021.07.030
10.1016/j.rmed.2020.106045
10.1183/09031936.06.00131905
10.1016/j.jaci.2020.06.001
10.1016/j.dsx.2020.07.005
10.1016/j.jaci.2020.08.008
10.2147/COPD.S276692
10.1371/journal.pone.0244051
10.1016/S0140-6736(20)30566-3
10.1016/j.cmi.2021.04.010
10.1016/S0140-6736(20)30183-5
10.1016/j.rmed.2020.106275
10.1016/j.jaci.2020.07.018
10.1183/16000617.0274-2021
10.1056/NEJMoa2004500
10.54724/lc.2022.e9
10.1007/s11606-020-06120-6
10.4187/respcare.08319
10.1016/j.jaip.2021.02.041
10.1016/j.jcv.2020.104577
10.1371/journal.pone.0250400
10.1371/journal.pone.0235248
10.1016/j.jinf.2020.09.024
10.5152/dir.2020.20346
10.1186/s12879-021-06600-y
10.1016/j.cmi.2020.09.023
10.1002/alr.22464
10.1111/all.14657
10.1016/j.ajog.2020.12.1221
10.1080/23744235.2021.1887510
10.1177/21501327211010991
10.1016/S2213-2600(22)00002-9
10.1161/HYPERTENSIONAHA.120.15324
10.1371/journal.pone.0255544
10.1038/s41586-020-2521-4
10.1007/s00330-020-07269-8
10.1016/j.jinf.2020.03.019
10.1016/j.ijid.2020.05.107
10.1016/j.ijid.2021.12.357
10.1186/s12879-020-05154-9
10.1016/j.alit.2018.01.002
10.1371/journal.pone.0252576
10.1038/s41598-020-77791-8
10.15585/mmwr.mm6942e3
10.1371/journal.pone.0254671
10.1016/j.jaci.2020.05.049
10.1186/s13293-021-00359-2
10.26719/emhj.18.014
10.1016/j.jaip.2020.05.006
10.1038/s41598-020-79508-3
10.1016/j.intimp.2020.107205
10.1001/jama.2020.2648
10.1111/eci.13603
10.1016/S0140-6736(20)31189-2
10.1016/j.arbres.2020.11.012
10.1016/j.jaip.2020.12.045
10.1016/j.jaip.2020.10.021
10.1186/s13024-021-00469-w
10.1001/jamanetworkopen.2021.3071
10.1016/j.anai.2021.02.021
10.2147/COPD.S318000
10.1093/gerona/glaa183
10.1111/cea.13855
10.1093/cid/ciaa242
10.1136/bmj.323.7308.334
10.1016/j.intimp.2021.108390
10.1371/journal.pone.0248009
10.1148/radiol.2020201754
10.1111/all.15041
10.1016/j.jclinepi.2010.07.015
10.1016/j.accpm.2020.04.001
10.1111/crj.12917
10.1016/j.rmed.2020.105938
10.1093/ije/dyab008
10.1016/j.jaci.2020.06.010
10.1093/gerona/glaa163
10.1016/j.cmi.2020.06.018
10.1016/j.intimp.2021.107407
10.1371/journal.ppat.1009416
10.1007/s12325-021-01742-6
10.1186/s12879-020-05683-3
10.3390/ijerph18179018
10.1007/s11606-021-06626-7
10.1016/j.rmed.2021.106384
10.1080/17476348.2021.1923484
10.1136/bmj.m1996
10.1186/s12985-021-01575-3
10.1001/jamanetworkopen.2020.22310
10.7754/Clin.Lab.2020.200844
10.1016/j.jaci.2011.10.024
10.1136/bmjopen-2020-044052
10.1111/all.14238
10.1016/j.jaci.2021.06.006
10.1038/s41598-021-83226-9
ContentType Journal Article
Copyright COPYRIGHT 2022 Public Library of Science
2022 Uruma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 Uruma et al 2022 Uruma et al
Copyright_xml – notice: COPYRIGHT 2022 Public Library of Science
– notice: 2022 Uruma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 Uruma et al 2022 Uruma et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
COVID
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0276774
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Opposing Viewpoints In Context
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Coronavirus Research Database
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals - May need to register for free articles
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



MEDLINE
Agricultural Science Database


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
DocumentTitleAlternate Asthma, COPD, and ACO in COVID-19: A systematic review and meta-analysis
EISSN 1932-6203
ExternalDocumentID 2731034554
oai_doaj_org_article_12c8a3c759444005a0325328995da912
PMC9624422
A724770703
36318528
10_1371_journal_pone_0276774
Genre Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Journal Article
GeographicLocations Japan
Netherlands
United Kingdom--UK
United States--US
China
GeographicLocations_xml – name: Japan
– name: China
– name: Netherlands
– name: United Kingdom--UK
– name: United States--US
GrantInformation_xml – fundername: ;
  grantid: 20345310
– fundername: ;
  grantid: 20KK0218
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
3V.
ADRAZ
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
COVID
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
AAPBV
ABPTK
BBAFP
N95
ID FETCH-LOGICAL-c758t-65079676f66fed2fecfb4febdfc364f724d7ad0325b894d36865f4466ea296613
IEDL.DBID M48
ISSN 1932-6203
IngestDate Mon Dec 05 23:08:12 EST 2022
Wed Aug 27 01:27:57 EDT 2025
Thu Aug 21 18:38:28 EDT 2025
Mon Jul 21 10:31:23 EDT 2025
Fri Jul 25 10:20:49 EDT 2025
Tue Jun 17 21:11:35 EDT 2025
Tue Jun 10 20:39:44 EDT 2025
Fri Jun 27 04:38:44 EDT 2025
Fri Jun 27 04:53:46 EDT 2025
Thu May 22 21:21:51 EDT 2025
Wed Feb 19 02:07:26 EST 2025
Thu Apr 24 23:09:03 EDT 2025
Tue Jul 01 03:23:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-65079676f66fed2fecfb4febdfc364f724d7ad0325b894d36865f4466ea296613
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0002-8208-8071
0000-0002-9595-9657
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0276774
PMID 36318528
PQID 2731034554
PQPubID 1436336
PageCount e0276774
ParticipantIDs plos_journals_2731034554
doaj_primary_oai_doaj_org_article_12c8a3c759444005a0325328995da912
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9624422
proquest_miscellaneous_2731056888
proquest_journals_2731034554
gale_infotracmisc_A724770703
gale_infotracacademiconefile_A724770703
gale_incontextgauss_ISR_A724770703
gale_incontextgauss_IOV_A724770703
gale_healthsolutions_A724770703
pubmed_primary_36318528
crossref_citationtrail_10_1371_journal_pone_0276774
crossref_primary_10_1371_journal_pone_0276774
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-01
PublicationDateYYYYMMDD 2022-11-01
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2022
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References JP Higgins (pone.0276774.ref024) 2003; 327
A De Vito (pone.0276774.ref049) 2020; 24
S Nanda (pone.0276774.ref093) 2021; 12
Y Yordanov (pone.0276774.ref102) 2021; 27
RA Seaton (pone.0276774.ref063) 2020; 81
M Mahdavinia (pone.0276774.ref031) 2020; 8
H Balshem (pone.0276774.ref021) 2011; 64
A Mendy (pone.0276774.ref138) 2018; 12
M Varmaghani (pone.0276774.ref010) 2019; 25
CF Vogelmeier (pone.0276774.ref013) 2020; 166
World Health Organization (pone.0276774.ref002) 2022; 30
L Klimek (pone.0276774.ref133) 2021; 76
C Corsini Campioli (pone.0276774.ref056) 2020; 130
YV Chudasama (pone.0276774.ref121) 2021; 21
J Xiao (pone.0276774.ref076) 2020; 20
F Abdullah (pone.0276774.ref125) 2022; 116
MA Pérez-Sastré (pone.0276774.ref052) 2020; 156
OY Bello-Chavolla (pone.0276774.ref078) 2020; 15
Q Xiong (pone.0276774.ref062) 2021; 27
F Zhou (pone.0276774.ref003) 2020; 395
C Huang (pone.0276774.ref001) 2020; 395
P Sen (pone.0276774.ref007) 2021; 16
J Song (pone.0276774.ref046) 2021; 76
A Chatterjee (pone.0276774.ref101) 2021; 16
G Giovannetti (pone.0276774.ref097) 2021; 181
Z Zhu (pone.0276774.ref038) 2020; 146
S Mulpuru (pone.0276774.ref128) 2019; 155
J Signes-Costa (pone.0276774.ref077) 2021; 57
D Calmes (pone.0276774.ref067) 2021; 9
Y He (pone.0276774.ref057) 2020; 26
C Mattiuzzi (pone.0276774.ref009) 2020; 10
A. Liberati (pone.0276774.ref018) 2009
M Sandoval (pone.0276774.ref114) 2021; 16
Z Wu (pone.0276774.ref123) 2020; 323
A Aggarwal (pone.0276774.ref043) 2020; 68
D Ferastraoaru (pone.0276774.ref008) 2021; 9
SC Lee (pone.0276774.ref074) 2020; 10
M Schiavone (pone.0276774.ref066) 2021; 323
A Chandel (pone.0276774.ref006) 2021; 66
F Lobelo (pone.0276774.ref100) 2021; 11
BZ Huang (pone.0276774.ref135) 2021; 9
A Schultze (pone.0276774.ref137) 2020; 8
C Lombardi (pone.0276774.ref132) 2020; 125
MJ Cummings (pone.0276774.ref037) 2020; 395
EM Lokken (pone.0276774.ref115) 2021; 225
F Bravi (pone.0276774.ref045) 2020; 15
Review Manager (RevMan) (pone.0276774.ref025) 2014
JLN Girkin (pone.0276774.ref122) 2022; 31
D.F. Stroup (pone.0276774.ref019) 2000; 283
Y Sun (pone.0276774.ref118) 2021; 27
EJ Williamson (pone.0276774.ref110) 2020; 584
OY Bello-Chavolla (pone.0276774.ref004) 2021; 76
DJ Jackson (pone.0276774.ref124) 2011; 128
S Tsai (pone.0276774.ref099) 2021; 11
SW Lee (pone.0276774.ref020) 2022; 2
W Lieberman-Cribbin (pone.0276774.ref041) 2020; 158
BT Garibaldi (pone.0276774.ref096) 2021; 4
D Munblit (pone.0276774.ref113) 2021; 51
JH Laake (pone.0276774.ref084) 2021; 65
P Li (pone.0276774.ref032) 2020; 97
MG Argenziano (pone.0276774.ref036) 2020; 369
NF Fernández-Martínez (pone.0276774.ref119) 2021; 18
X Hou (pone.0276774.ref105) 2021; 18
Y Yoshida (pone.0276774.ref092) 2021; 12
BG Cosio (pone.0276774.ref107) 2021; 16
M Riou (pone.0276774.ref103) 2021; 51
N Zaki (pone.0276774.ref136) 2020; 14
JL Atkins (pone.0276774.ref050) 2020; 75
S Chaudhary (pone.0276774.ref109) 2021; 66
WCG Fong (pone.0276774.ref088) 2021; 51
X Han (pone.0276774.ref126) 2022; 102
A Beurnier (pone.0276774.ref127) 2020; 56
M Jongbloed (pone.0276774.ref089) 2021; 53
SS Hasan (pone.0276774.ref134) 2020; 170
A Agresti (pone.0276774.ref023) 1998; 52
O Turan (pone.0276774.ref029) 2021; 15
SG Chandrupatla (pone.0276774.ref140) 2017; 18
PK Bhatraju (pone.0276774.ref028) 2020; 382
R Harbour (pone.0276774.ref022) 2001; 323
Y Adir (pone.0276774.ref108) 2021; 148
D Toussie (pone.0276774.ref035) 2020; 297
N Goel (pone.0276774.ref059) 2020; 90
D Meza (pone.0276774.ref117) 2021; 16
Z Zhao (pone.0276774.ref051) 2020; 15
JJ Zhang (pone.0276774.ref026) 2020; 75
L Wang (pone.0276774.ref027) 2020; 80
YD Gao (pone.0276774.ref015) 2021; 76
MH Hussein (pone.0276774.ref072) 2020; 175
S Yanagisawa (pone.0276774.ref014) 2018; 67
Y Yao (pone.0276774.ref040) 2020; 26
GN Ioannou (pone.0276774.ref061) 2020; 3
MJ Rial (pone.0276774.ref068) 2021; 9
J Mushtaq (pone.0276774.ref058) 2021; 31
S Jungo (pone.0276774.ref086) 2021; 16
M Grandbastien (pone.0276774.ref039) 2020; 8
M Canevelli (pone.0276774.ref048) 2020; 56
MI Restrepo (pone.0276774.ref129) 2006; 28
R Güner (pone.0276774.ref053) 2020; 50
SS Somani (pone.0276774.ref054) 2020; 35
G Akpinar (pone.0276774.ref065) 2021; 67
NJ Brendish (pone.0276774.ref060) 2020; 81
MS Khan (pone.0276774.ref098) 2021; 16
SY Liao (pone.0276774.ref005) 2021; 176
P Tabarsi (pone.0276774.ref073) 2021; 90
EM Lokken (pone.0276774.ref079) 2020; 223
A Abayomi (pone.0276774.ref111) 2021; 6
J Wang (pone.0276774.ref042) 2020; 20
JM Yang (pone.0276774.ref055) 2020; 146
A Artero (pone.0276774.ref090) 2021; 36
KD Chhiba (pone.0276774.ref131) 2020; 146
T Rothe (pone.0276774.ref012) 2018; 95
JR Baker (pone.0276774.ref130) 2022; 10
SC Lee (pone.0276774.ref085) 2021; 11
JC Cataño-Correa (pone.0276774.ref116) 2021; 16
YH Liu (pone.0276774.ref112) 2021; 16
M Caminati (pone.0276774.ref044) 2020; 146
Y Jiang (pone.0276774.ref075) 2020; 10
E Değerli (pone.0276774.ref083) 2021; 93
pone.0276774.ref141
C Leung (pone.0276774.ref011) 2021; 6S0012-3692
M Valverde-Monge (pone.0276774.ref106) 2021; 12
KS Ho (pone.0276774.ref091) 2021; 127
G Iaccarino (pone.0276774.ref034) 2020; 76
pone.0276774.ref139
J Cates (pone.0276774.ref070) 2020; 69
L Cao (pone.0276774.ref087) 2021; 126
Y Wang (pone.0276774.ref016) 2021; 182
MP Abrams (pone.0276774.ref064) 2020; 31
M Gómez Antúnez (pone.0276774.ref080) 2021; 15
H Barrasa (pone.0276774.ref030) 2020; 39
LB Robinson (pone.0276774.ref069) 2021; 9
E Monterrubio-Flores (pone.0276774.ref081) 2021; 50
A De Vito (pone.0276774.ref094) 2021; 16
WJ Guan (pone.0276774.ref017) 2021; 9
S Cosma (pone.0276774.ref120) 2021; 16
C Rodriguez (pone.0276774.ref095) 2021; 17
J Lian (pone.0276774.ref033) 2020; 71
L Wang (pone.0276774.ref047) 2020; 146
E Mortaz (pone.0276774.ref082) 2021; 93
DE Tekcan Şanlı (pone.0276774.ref071) 2021; 27
W Wei (pone.0276774.ref104) 2021; 38
References_xml – volume: 51
  start-page: 1107
  issue: 9
  year: 2021
  ident: pone.0276774.ref113
  article-title: Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19
  publication-title: Clin Exp Allergy
  doi: 10.1111/cea.13997
– volume: 158
  start-page: 2290
  issue: 6
  year: 2020
  ident: pone.0276774.ref041
  article-title: The Impact of Asthma on Mortality in Patients With COVID-19
  publication-title: Chest
  doi: 10.1016/j.chest.2020.05.575
– volume: 283
  start-page: 2008
  year: 2000
  ident: pone.0276774.ref019
  article-title: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group
  publication-title: J Am Med Assoc
  doi: 10.1001/jama.283.15.2008
– volume: 95
  start-page: 364
  issue: 5
  year: 2018
  ident: pone.0276774.ref012
  article-title: Diagnosis and Management of Asthma–The Swiss Guidelines
  publication-title: Respiration
  doi: 10.1159/000486797
– volume: 9
  start-page: 487
  issue: 1
  year: 2021
  ident: pone.0276774.ref068
  article-title: Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2020.09.050
– volume: 56
  start-page: 2001875
  issue: 5
  year: 2020
  ident: pone.0276774.ref127
  article-title: Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
  publication-title: Eur Respir J
  doi: 10.1183/13993003.01875-2020
– volume: 11
  start-page: 8497
  issue: 1
  year: 2021
  ident: pone.0276774.ref099
  article-title: COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-88111-z
– volume: 16
  start-page: e0249920
  issue: 4
  year: 2021
  ident: pone.0276774.ref101
  article-title: Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0249920
– volume: 50
  start-page: 1801
  issue: 8
  year: 2020
  ident: pone.0276774.ref053
  article-title: COVID-19 experience of the major pandemic response center in the capital: results of the pandemic’s first month in Turkey
  publication-title: Turk J Med Sci
  doi: 10.3906/sag-2006-164
– volume: 182
  start-page: 76
  issue: 1
  year: 2021
  ident: pone.0276774.ref016
  article-title: Does Asthma Increase the Mortality of Patients with COVID-19?: A Systematic Review and Meta-Analysis
  publication-title: Int Arch Allergy Immunol
  doi: 10.1159/000510953
– volume: 81
  start-page: 937
  issue: 6
  year: 2020
  ident: pone.0276774.ref060
  article-title: Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection
  publication-title: J Infect
  doi: 10.1016/j.jinf.2020.09.033
– volume: 90
  issue: 4
  year: 2020
  ident: pone.0276774.ref059
  article-title: Characteristics of COVID-19 at a non-COVID tertiary pulmonary care centre in Delhi, India
  publication-title: Monaldi Arch Chest Dis
  doi: 10.4081/monaldi.2020.1568
– volume: 66
  start-page: 909
  issue: 6
  year: 2021
  ident: pone.0276774.ref006
  article-title: High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success
  publication-title: Respir Care
  doi: 10.4187/respcare.08631
– volume: 175
  start-page: 106205
  year: 2020
  ident: pone.0276774.ref072
  article-title: Asthma in COVID-19 patients: An extra chain fitting around the neck?
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2020.106205
– volume: 9
  start-page: 160
  issue: 1
  year: 2021
  ident: pone.0276774.ref067
  article-title: Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2020.09.044
– year: 2014
  ident: pone.0276774.ref025
  publication-title: Computer program] Version 5.4.1 Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration
– volume: 155
  start-page: 69
  issue: 1
  year: 2019
  ident: pone.0276774.ref128
  article-title: Effectiveness of Influenza Vaccination on Hospitalizations and Risk Factors for Severe Outcomes in Hospitalized Patients With COPD
  publication-title: Chest
  doi: 10.1016/j.chest.2018.10.044
– volume: 327
  start-page: 557
  issue: 7414
  year: 2003
  ident: pone.0276774.ref024
  article-title: Measuring inconsistency in meta-analyses
  publication-title: BMJ
  doi: 10.1136/bmj.327.7414.557
– volume: 65
  start-page: 618
  issue: 5
  year: 2021
  ident: pone.0276774.ref084
  article-title: Characteristics, management and survival of ICU patients with coronavirus disease-19 in Norway, March-June 2020. A prospective observational study
  publication-title: Acta Anaesthesiol Scand
  doi: 10.1111/aas.13785
– volume: 76
  start-page: 483
  issue: 2
  year: 2021
  ident: pone.0276774.ref046
  article-title: Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19
  publication-title: Allergy
  doi: 10.1111/all.14517
– volume: 6
  start-page: 26
  issue: 1
  year: 2021
  ident: pone.0276774.ref111
  article-title: Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study
  publication-title: Glob Health Res Policy
  doi: 10.1186/s41256-021-00210-6
– ident: pone.0276774.ref141
– volume: 31
  start-page: 3086
  issue: 12
  year: 2020
  ident: pone.0276774.ref064
  article-title: Clinical and cardiac characteristics of COVID-19 mortalities in a diverse New York City Cohort
  publication-title: J Cardiovasc Electrophysiol
  doi: 10.1111/jce.14772
– volume: 223
  start-page: 911.e1
  issue: 6
  year: 2020
  ident: pone.0276774.ref079
  article-title: Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2020.05.031
– volume: 126
  start-page: 535
  issue: 5
  year: 2021
  ident: pone.0276774.ref087
  article-title: Asthma in patients with suspected and diagnosed coronavirus disease 2019
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2021.02.020
– volume: 8
  start-page: 2600
  issue: 8
  year: 2020
  ident: pone.0276774.ref039
  article-title: SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2020.06.032
– volume: 16
  start-page: e0254875
  issue: 8
  year: 2021
  ident: pone.0276774.ref120
  article-title: Preterm birth is not associated with asymptomatic/mild SARS-CoV-2 infection per se: Pre-pregnancy state is what matters
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0254875
– volume: 12
  start-page: 668074
  year: 2021
  ident: pone.0276774.ref106
  article-title: Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.668074
– volume: 125
  start-page: 707
  issue: 6
  year: 2020
  ident: pone.0276774.ref132
  article-title: Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2020.07.029
– volume: 26
  start-page: e927212
  year: 2020
  ident: pone.0276774.ref057
  article-title: Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD)
  publication-title: Med Sci Monit
– volume: 323
  start-page: 276
  year: 2021
  ident: pone.0276774.ref066
  article-title: Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2020.09.001
– volume: 68
  start-page: 19
  issue: 7
  year: 2020
  ident: pone.0276774.ref043
  article-title: Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi
  publication-title: J Assoc Physicians India
– volume: 16
  start-page: e0246586
  issue: 2
  year: 2021
  ident: pone.0276774.ref086
  article-title: Prevalence and risk indicators of first-wave COVID-19 among oral health-care workers: A French epidemiological survey
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0246586
– volume: 8
  start-page: 1106
  issue: 11
  year: 2020
  ident: pone.0276774.ref137
  article-title: Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30415-X
– volume: 93
  start-page: 5839
  issue: 10
  year: 2021
  ident: pone.0276774.ref083
  article-title: The demographic characteristics, prognosis, and relationship with cancer subtypes of hospitalized COVID-19 patients with malignancy: A single-center experience
  publication-title: J Med Virol
  doi: 10.1002/jmv.27123
– volume: 16
  start-page: 1549
  year: 2021
  ident: pone.0276774.ref107
  article-title: Characterization of COPD Admissions During the First COVID-19 Outbreak
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S312493
– volume: 15
  start-page: e0236618
  issue: 7
  year: 2020
  ident: pone.0276774.ref051
  article-title: Prediction model and risk scores of ICU admission and mortality in COVID-19
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0236618
– volume: 9
  start-page: 3621
  issue: 10
  year: 2021
  ident: pone.0276774.ref135
  article-title: Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2021.07.030
– volume: 170
  start-page: 106045
  year: 2020
  ident: pone.0276774.ref134
  article-title: Use of corticosteroids in asthma and COPD patients with or without COVID-19
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2020.106045
– volume: 6S0012-3692
  start-page: 04078
  issue: 21
  year: 2021
  ident: pone.0276774.ref011
  article-title: Asthma-COPD Overlap: What Are the Important Questions?
  publication-title: Chest
– volume: 52
  start-page: 119
  year: 1998
  ident: pone.0276774.ref023
  article-title: Approximate is better than “exact” for interval estimation of binomial proportions
  publication-title: Am Stat
– volume: 28
  start-page: 346
  issue: 2
  year: 2006
  ident: pone.0276774.ref129
  article-title: COPD is associated with increased mortality in patients with community-acquired pneumonia
  publication-title: Eur Respir J
  doi: 10.1183/09031936.06.00131905
– volume: 146
  start-page: 327
  issue: 2
  year: 2020
  ident: pone.0276774.ref038
  article-title: Association of asthma and its genetic predisposition with the risk of severe COVID-19
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.06.001
– volume: 14
  start-page: 1133
  issue: 5
  year: 2020
  ident: pone.0276774.ref136
  article-title: Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review
  publication-title: Diabetes Metab Syndr
  doi: 10.1016/j.dsx.2020.07.005
– volume: 146
  start-page: 790
  issue: 4
  year: 2020
  ident: pone.0276774.ref055
  article-title: Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.08.008
– volume: 15
  start-page: 3433
  year: 2021
  ident: pone.0276774.ref080
  article-title: Clinical Characteristics and Prognosis of COPD Patients Hospitalized with SARS-CoV-2
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S276692
– volume: 15
  start-page: e0244051
  issue: 12
  year: 2020
  ident: pone.0276774.ref078
  article-title: Validation and repurposing of the MSL-COVID-19 score for prediction of severe COVID-19 using simple clinical predictors in a triage setting: The Nutri-CoV score
  publication-title: PLoS OneDec 16
  doi: 10.1371/journal.pone.0244051
– volume: 18
  start-page: 1861
  issue: 7
  year: 2017
  ident: pone.0276774.ref140
  article-title: Tobacco Use and Effects of Professional Advice on Smoking Cessation among Youth in India
  publication-title: Asian Pac J Cancer Prev
– volume: 395
  start-page: 1054
  issue: 10229
  year: 2020
  ident: pone.0276774.ref003
  article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30566-3
– volume: 27
  start-page: 1158
  issue: 8
  year: 2021
  ident: pone.0276774.ref102
  article-title: Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2021.04.010
– volume: 395
  start-page: 497
  issue: 10223
  year: 2020
  ident: pone.0276774.ref001
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 176
  start-page: 106275
  year: 2021
  ident: pone.0276774.ref005
  article-title: Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2020.106275
– volume: 146
  start-page: 808
  issue: 4
  year: 2020
  ident: pone.0276774.ref047
  article-title: Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.07.018
– volume: 31
  start-page: 210274
  issue: 164
  year: 2022
  ident: pone.0276774.ref122
  article-title: Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
  publication-title: Eur Respir Rev
  doi: 10.1183/16000617.0274-2021
– volume: 382
  start-page: 2012
  issue: 21
  year: 2020
  ident: pone.0276774.ref028
  article-title: Covid-19 in Critically Ill Patients in the Seattle Region—Case Series
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2004500
– volume: 2
  start-page: e9
  year: 2022
  ident: pone.0276774.ref020
  article-title: PRISMA 2020 statement and guidelines for systematic review and meta-analysis articles, and their underlying mathematics: Life Cycle Committee Recommendations
  publication-title: Life Cycle
  doi: 10.54724/lc.2022.e9
– volume: 35
  start-page: 2838
  issue: 10
  year: 2020
  ident: pone.0276774.ref054
  article-title: Characterization of Patients Who Return to Hospital Following Discharge from Hospitalization for COVID-19
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-020-06120-6
– volume: 66
  start-page: 897
  issue: 6
  year: 2021
  ident: pone.0276774.ref109
  article-title: Clinical Characteristics, Respiratory Mechanics, and Outcomes in Critically Ill Individuals With COVID-19 Infection in an Underserved Urban Population
  publication-title: Respir Care
  doi: 10.4187/respcare.08319
– volume: 9
  start-page: 2645
  issue: 7
  year: 2021
  ident: pone.0276774.ref017
  article-title: Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2021.02.041
– volume: 130
  start-page: 104577
  year: 2020
  ident: pone.0276774.ref056
  article-title: Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2020.104577
– volume: 16
  start-page: e0250400
  issue: 4
  year: 2021
  ident: pone.0276774.ref098
  article-title: Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0250400
– volume: 15
  start-page: e0235248
  issue: 6
  year: 2020
  ident: pone.0276774.ref045
  article-title: Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0235248
– volume: 81
  start-page: 952
  issue: 6
  year: 2020
  ident: pone.0276774.ref063
  article-title: Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals
  publication-title: J Infect
  doi: 10.1016/j.jinf.2020.09.024
– volume: 27
  start-page: 172
  issue: 2
  year: 2021
  ident: pone.0276774.ref071
  article-title: A new imaging sign in COVID-19 pneumonia: vascular changes and their correlation with clinical severity of the disease
  publication-title: Diagn Interv Radiol
  doi: 10.5152/dir.2020.20346
– volume: 21
  start-page: 908
  issue: 1
  year: 2021
  ident: pone.0276774.ref121
  article-title: Patterns of multimorbidity and risk of severe SARS-CoV-2 infection: an observational study in the U.K.
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-021-06600-y
– volume: 27
  start-page: 89
  issue: 1
  year: 2021
  ident: pone.0276774.ref062
  article-title: Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2020.09.023
– volume: 10
  start-page: 75
  issue: 1
  year: 2020
  ident: pone.0276774.ref009
  article-title: Worldwide asthma epidemiology: insights from the Global Health Data Exchange database
  publication-title: Int Forum Allergy Rhinol
  doi: 10.1002/alr.22464
– start-page: 339 b2700
  year: 2009
  ident: pone.0276774.ref018
  article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
  publication-title: BMJ
– volume: 76
  start-page: 428
  issue: 2
  year: 2021
  ident: pone.0276774.ref015
  article-title: Risk factors for severe and critically ill COVID-19 patients: A review
  publication-title: Allergy
  doi: 10.1111/all.14657
– volume: 225
  start-page: 77.e1
  issue: 1
  year: 2021
  ident: pone.0276774.ref115
  article-title: Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State
  publication-title: Am J Obstet Gynecol
  doi: 10.1016/j.ajog.2020.12.1221
– volume: 53
  start-page: 488
  issue: 7
  year: 2021
  ident: pone.0276774.ref089
  article-title: Clinical impact of human metapneumovirus infections before and during the COVID-19 pandemic
  publication-title: Infect Dis (Lond)
  doi: 10.1080/23744235.2021.1887510
– volume: 12
  start-page: 21501327211010991
  year: 2021
  ident: pone.0276774.ref093
  article-title: A Midwest COVID-19 Cohort for the Evaluation of Multimorbidity and Adverse Outcomes from COVID-19
  publication-title: J Prim Care Community Health
  doi: 10.1177/21501327211010991
– volume: 10
  start-page: 545
  issue: 6
  year: 2022
  ident: pone.0276774.ref130
  article-title: Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(22)00002-9
– volume: 76
  start-page: 366
  issue: 2
  year: 2020
  ident: pone.0276774.ref034
  article-title: Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.120.15324
– volume: 16
  start-page: e0255544
  issue: 7
  year: 2021
  ident: pone.0276774.ref114
  article-title: Risk factors for severity of COVID-19 in hospital patients age 18–29 years
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0255544
– volume: 584
  start-page: 430
  issue: 7821
  year: 2020
  ident: pone.0276774.ref110
  article-title: Factors associated with COVID-19-related death using OpenSAFELY
  publication-title: Nature
  doi: 10.1038/s41586-020-2521-4
– volume: 31
  start-page: 1770
  issue: 3
  year: 2021
  ident: pone.0276774.ref058
  article-title: Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients
  publication-title: Eur Radiol
  doi: 10.1007/s00330-020-07269-8
– volume: 80
  start-page: 639
  issue: 6
  year: 2020
  ident: pone.0276774.ref027
  article-title: Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up
  publication-title: J Infect
  doi: 10.1016/j.jinf.2020.03.019
– volume: 24
  start-page: 7861
  issue: 14
  year: 2020
  ident: pone.0276774.ref049
  article-title: Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy
  publication-title: Eur Rev Med Pharmacol Sci
– volume: 97
  start-page: 245
  year: 2020
  ident: pone.0276774.ref032
  article-title: Clinical features and short-term outcomes of elderly patients with COVID-19
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2020.05.107
– volume: 116
  start-page: 38
  year: 2022
  ident: pone.0276774.ref125
  article-title: Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
  publication-title: Int J Infect Dis
  doi: 10.1016/j.ijid.2021.12.357
– volume: 20
  start-page: 434
  issue: 1
  year: 2020
  ident: pone.0276774.ref042
  article-title: Clinical and CT findings of COVID-19: differences among three age groups
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-020-05154-9
– volume: 67
  start-page: 172
  issue: 2
  year: 2018
  ident: pone.0276774.ref014
  article-title: Definition and diagnosis of asthma-COPD overlap (ACO)
  publication-title: Allergol Int
  doi: 10.1016/j.alit.2018.01.002
– volume: 16
  start-page: e0252576
  issue: 6
  year: 2021
  ident: pone.0276774.ref007
  article-title: Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic’s COVID-19 registry
  publication-title: PloS One
  doi: 10.1371/journal.pone.0252576
– volume: 10
  start-page: 21805
  issue: 1
  year: 2020
  ident: pone.0276774.ref074
  article-title: Impact of comorbid asthma on severity of coronavirus disease (COVID-19)
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-77791-8
– volume: 69
  start-page: 1528
  issue: 42
  year: 2020
  ident: pone.0276774.ref070
  article-title: Risk for In-Hospital Complications Associated with COVID-19 and Influenza—Veterans Health Administration, United States, October 1, 2018-May 31, 2020
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6942e3
– volume: 16
  start-page: e0254671
  issue: 7
  year: 2021
  ident: pone.0276774.ref116
  article-title: Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0254671
– volume: 146
  start-page: 541
  issue: 3
  year: 2020
  ident: pone.0276774.ref044
  article-title: Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.05.049
– volume: 12
  start-page: 20
  issue: 1
  year: 2021
  ident: pone.0276774.ref092
  article-title: Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans
  publication-title: Biol Sex Differ
  doi: 10.1186/s13293-021-00359-2
– volume: 56
  start-page: 373
  issue: 3
  year: 2020
  ident: pone.0276774.ref048
  article-title: COVID-19 mortality among migrants living in Italy
  publication-title: Ann Ist Super Sanita
– volume: 25
  start-page: 47
  issue: 1
  year: 2019
  ident: pone.0276774.ref010
  article-title: Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis
  publication-title: East Mediterr Health J
  doi: 10.26719/emhj.18.014
– volume: 8
  start-page: 2388
  issue: 7
  year: 2020
  ident: pone.0276774.ref031
  article-title: Asthma prolongs intubation in COVID-19
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2020.05.006
– volume: 10
  start-page: 22369
  issue: 1
  year: 2020
  ident: pone.0276774.ref075
  article-title: Risk factors associated with 28-day all-cause mortality in older severe COVID-19 patients in Wuhan, China: a retrospective observational study
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-79508-3
– volume: 90
  start-page: 107205
  year: 2021
  ident: pone.0276774.ref073
  article-title: Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2020.107205
– volume: 323
  start-page: 1239
  issue: 13
  year: 2020
  ident: pone.0276774.ref123
  article-title: Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention
  publication-title: JAMA
  doi: 10.1001/jama.2020.2648
– volume: 156
  start-page: 373
  issue: 5
  year: 2020
  ident: pone.0276774.ref052
  article-title: Clinical characteristics and severity of COVID-19 among Mexican adults
  publication-title: Gac Med Mex
– volume: 51
  start-page: e13603
  issue: 8
  year: 2021
  ident: pone.0276774.ref103
  article-title: Respiratory follow-up after hospitalization for COVID-19: Who and when?
  publication-title: Eur J Clin Invest
  doi: 10.1111/eci.13603
– volume: 395
  start-page: 1763
  issue: 10239
  year: 2020
  ident: pone.0276774.ref037
  article-title: Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31189-2
– volume: 57
  start-page: 13
  year: 2021
  ident: pone.0276774.ref077
  article-title: Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases
  publication-title: Arch Bronconeumol
  doi: 10.1016/j.arbres.2020.11.012
– volume: 9
  start-page: 1152
  issue: 3
  year: 2021
  ident: pone.0276774.ref008
  article-title: Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2020.12.045
– volume: 9
  start-page: 497
  issue: 1
  year: 2021
  ident: pone.0276774.ref069
  article-title: COVID-19 severity in hospitalized patients with asthma: A matched cohort study
  publication-title: J Allergy Clin Immunol Pract
  doi: 10.1016/j.jaip.2020.10.021
– volume: 16
  start-page: 48
  issue: 1
  year: 2021
  ident: pone.0276774.ref112
  article-title: Post-infection cognitive impairments in a cohort of elderly patients with COVID-19
  publication-title: Mol Neurodegener
  doi: 10.1186/s13024-021-00469-w
– volume: 4
  start-page: e213071
  issue: 3
  year: 2021
  ident: pone.0276774.ref096
  article-title: Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2021.3071
– volume: 127
  start-page: 42
  issue: 1
  year: 2021
  ident: pone.0276774.ref091
  article-title: The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2021.02.021
– volume: 16
  start-page: 2323
  year: 2021
  ident: pone.0276774.ref117
  article-title: Mortality from COVID-19 in Patients with COPD: A US Study in the N3C Data Enclave
  publication-title: Int J Chron Obstruct Pulmon Dis
  doi: 10.2147/COPD.S318000
– volume: 75
  start-page: 2224
  issue: 11
  year: 2020
  ident: pone.0276774.ref050
  article-title: Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glaa183
– volume: 51
  start-page: 939
  issue: 7
  year: 2021
  ident: pone.0276774.ref088
  article-title: Asthma did not increase in-hospital COVID-19-related mortality in a tertiary UK hospital
  publication-title: Clin Exp Allergy
  doi: 10.1111/cea.13855
– volume: 71
  start-page: 740
  issue: 15
  year: 2020
  ident: pone.0276774.ref033
  article-title: Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside Wuhan
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa242
– volume: 323
  start-page: 334
  issue: 7308
  year: 2001
  ident: pone.0276774.ref022
  article-title: A new system for grading recommendations in evidence based guidelines
  publication-title: BMJ
  doi: 10.1136/bmj.323.7308.334
– volume: 102
  start-page: 108390
  year: 2022
  ident: pone.0276774.ref126
  article-title: Impact of asthma on COVID-19 mortality in the United States: Evidence based on a meta-analysis
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.108390
– volume: 16
  start-page: e0248009
  issue: 3
  year: 2021
  ident: pone.0276774.ref094
  article-title: Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0248009
– volume: 297
  start-page: E197
  issue: 1
  year: 2020
  ident: pone.0276774.ref035
  article-title: Clinical and Chest Radiography Features Determine Patient Outcomes in Young and Middle-aged Adults with COVID-19
  publication-title: Radiology
  doi: 10.1148/radiol.2020201754
– volume: 27
  start-page: e932156
  year: 2021
  ident: pone.0276774.ref118
  article-title: A Retrospective Study of 268 Patients with SARS-CoV-2 Infection to Evaluate the Association Between Blood Glucose and Severity of COVID-19 Pneumonia and Patient Mortality
  publication-title: Med Sci Monit
– volume: 76
  start-page: 3540
  issue: 11
  year: 2021
  ident: pone.0276774.ref133
  article-title: Inhaled corticosteroids in early COVID-19-A tale of many facets
  publication-title: Allergy
  doi: 10.1111/all.15041
– volume: 64
  start-page: 401
  issue: 4
  year: 2011
  ident: pone.0276774.ref021
  article-title: GRADE guidelines: 3. Rating the quality of evidence
  publication-title: Clin Epidemiol
  doi: 10.1016/j.jclinepi.2010.07.015
– volume: 39
  start-page: 553
  issue: 5
  year: 2020
  ident: pone.0276774.ref030
  article-title: SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria
  publication-title: Anaesth Crit Care Pain Med
  doi: 10.1016/j.accpm.2020.04.001
– volume: 12
  start-page: 2369
  issue: 8
  year: 2018
  ident: pone.0276774.ref138
  article-title: Prevalence and features of asthma-COPD overlap in the United States 2007–2012
  publication-title: Clin Respir J
  doi: 10.1111/crj.12917
– volume: 166
  start-page: 105938
  year: 2020
  ident: pone.0276774.ref013
  article-title: Goals of COPD treatment: Focus on symptoms and exacerbations
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2020.105938
– volume: 50
  start-page: 430
  issue: 2
  year: 2021
  ident: pone.0276774.ref081
  article-title: Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/dyab008
– volume: 146
  start-page: 307
  issue: 2
  year: 2020
  ident: pone.0276774.ref131
  article-title: Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2020.06.010
– volume: 76
  start-page: e52
  issue: 3
  year: 2021
  ident: pone.0276774.ref004
  article-title: Unequal Impact of Structural Health Determinants and Comorbidity on COVID-19 Severity and Lethality in Older Mexican Adults: Considerations Beyond Chronological Aging
  publication-title: J Gerontol A Biol Sci Med Sci
  doi: 10.1093/gerona/glaa163
– volume: 26
  start-page: 1380
  issue: 10
  year: 2020
  ident: pone.0276774.ref040
  article-title: Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China
  publication-title: Clin Microbiol Infect
  doi: 10.1016/j.cmi.2020.06.018
– volume: 93
  start-page: 107407
  year: 2021
  ident: pone.0276774.ref082
  article-title: Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.107407
– volume: 17
  start-page: e1009416
  issue: 3
  year: 2021
  ident: pone.0276774.ref095
  article-title: Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1009416
– volume: 38
  start-page: 3185
  issue: 6
  year: 2021
  ident: pone.0276774.ref104
  article-title: A Retrospective Study of COVID-19-Related Urgent Medical Visits and Hospitalizations After Outpatient COVID-19 Diagnosis in the US
  publication-title: Adv Ther
  doi: 10.1007/s12325-021-01742-6
– volume: 20
  start-page: 953
  issue: 1
  year: 2020
  ident: pone.0276774.ref076
  article-title: Maximum chest CT score is associated with progression to severe illness in patients with COVID-19: a retrospective study from Wuhan, China
  publication-title: BMC Infect Dis
  doi: 10.1186/s12879-020-05683-3
– ident: pone.0276774.ref139
– volume: 30
  start-page: 2022
  year: 2022
  ident: pone.0276774.ref002
  article-title: WHO Director-General’s opening remarks at the media briefing on COVID-19
  publication-title: January
– volume: 18
  start-page: 9018
  issue: 17
  year: 2021
  ident: pone.0276774.ref119
  article-title: Sex Differences and Predictors of In-Hospital Mortality among Patients with COVID-19: Results from the ANCOHVID Multicentre Study
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph18179018
– volume: 36
  start-page: 1338
  issue: 5
  year: 2021
  ident: pone.0276774.ref090
  article-title: Severity Scores in COVID-19 Pneumonia: a Multicenter, Retrospective, Cohort Study
  publication-title: J Gen Intern Med
  doi: 10.1007/s11606-021-06626-7
– volume: 181
  start-page: 106384
  year: 2021
  ident: pone.0276774.ref097
  article-title: Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2021.106384
– volume: 15
  start-page: 1069
  issue: 8
  year: 2021
  ident: pone.0276774.ref029
  article-title: Clinical characteristics and outcomes of hospitalized COVID-19 patients with COPD
  publication-title: Expert Rev Respir Med
  doi: 10.1080/17476348.2021.1923484
– volume: 369
  start-page: m1996
  year: 2020
  ident: pone.0276774.ref036
  article-title: Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
  publication-title: BMJ
  doi: 10.1136/bmj.m1996
– volume: 18
  start-page: 101
  issue: 1
  year: 2021
  ident: pone.0276774.ref105
  article-title: Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
  publication-title: Virol J
  doi: 10.1186/s12985-021-01575-3
– volume: 3
  start-page: e2022310
  issue: 9
  year: 2020
  ident: pone.0276774.ref061
  article-title: Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10131 US Veterans With SARS-CoV-2 Infection
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2020.22310
– volume: 67
  start-page: 1058
  year: 2021
  ident: pone.0276774.ref065
  article-title: The Demographic Analysis of the Probable COVID-19 Cases in Terms of RT-PCR Results and Age
  publication-title: Clin. Lab
  doi: 10.7754/Clin.Lab.2020.200844
– volume: 128
  start-page: 1165
  issue: 6
  year: 2011
  ident: pone.0276774.ref124
  article-title: Asthma exacerbations: origin, effect, and prevention
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2011.10.024
– volume: 11
  start-page: e044052
  issue: 5
  year: 2021
  ident: pone.0276774.ref100
  article-title: Clinical, behavioural and social factors associated with racial disparities in COVID-19 patients from an integrated healthcare system in Georgia: a retrospective cohort study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-044052
– volume: 75
  start-page: 1730
  issue: 7
  year: 2020
  ident: pone.0276774.ref026
  article-title: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
  publication-title: Allergy
  doi: 10.1111/all.14238
– volume: 148
  start-page: 361
  issue: 2
  year: 2021
  ident: pone.0276774.ref108
  article-title: COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2021.06.006
– volume: 11
  start-page: 3735
  issue: 1
  year: 2021
  ident: pone.0276774.ref085
  article-title: Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-83226-9
SSID ssj0053866
Score 2.4933019
SecondaryResourceType review_article
Snippet The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as their risks...
Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as...
Introduction The prevalence of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO) in patients with COVID-19 varies, as well as...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0276774
SubjectTerms Asthma
Asthma - epidemiology
Chronic obstructive pulmonary disease
Cohort analysis
Comorbidity
Complications and side effects
Coronaviruses
COVID-19
COVID-19 - epidemiology
COVID-19 - mortality
COVID-19 - therapy
Health risks
Humans
Lung diseases
Lung diseases, Obstructive
Medicine and Health Sciences
Meta-analysis
Mortality
Mortality risk
Obstructive lung disease
Patients
People and Places
Physical Sciences
Prevalence
Pulmonary Disease, Chronic Obstructive - epidemiology
Research and Analysis Methods
Risk Assessment
SummonAdditionalLinks – databaseName: Directory of Open Access Journals - May need to register for free articles
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQnrggylcDBQxCAqS6TWzHdrgtW6qWA4sKrXqznDimSG2yItn_z9jxhgZVKgeumckm-2bGnlFmnhF6k6bWyrRUBPa2nHCTZ8QUxhHIRVJalcJmLnRbfBFHp_zzeX5-7agv3xM20AMPwO1ntFKGVTIvOAd_y03KaM58mZBbU4TzhSnseZtialiDIYqFiINyTGb70S57q7ap96AQE1LyyUYU-PrHVXm2umy7m1LOvzsnr21Fh_fRvZhD4vnw7lvoTt08QFsxSjv8LlJJv3-ITgZyYtw6bLr-4srs4sXy68EuNo3F88UStw1cODs-IFnxAc_xH15nPMy0BMWrujfERPaSR-j08NP3xRGJpygQAE31BFIwWQgpnBCuthSe6kru6tK6ignuJOVWGutRLVXBLRNK5M5_5a0NhVooY4_RrAHcthHmlKa-Iy5lJdiiUGB_KEjqXJWeEoibBLENpLqKFOP-pItLHb6bSSg1BoS0N4SOhkgQGe9aDRQbt-h_9NYadT1BdrgAbqOj2-jb3CZBL72t9TBtOoa5ngMeUvp1MEGvg4YnyWh8F84Ps-46fbw8-welbycTpbdRybUAR2Xi5AP8J0--NdHcmWhCqFcT8bb3zA0qnYbcM0sZh5QQ7tx4683iV6PY_6jvrGvqdh11cqGUStCTwblHZJkIs_UgkRO3n0A_lTQ_LwJHeSEgb6T06f-w1TN0l_qhkzABuoNm_a91_RxSwb58EaL-N3YSVJs
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegvPCCGF8rDDAICZDmLbEdO-EFlY6y8UDRYNPeIieON6QtKUv7_3PnuBlBE_Cau7TJffju4rufCXkVRdbqqEgZxLaESZPEzGTGMchFIl4WysbOd1t8UftH8vNJchI-uLWhrXK9JvqF2jYlfiPfhTAbR0JC9Hu_-Mnw1CjcXQ1HaNwkt2KINNjSlc4-rVdi8GWlwric0PFu0M7OoqmrHSjHlNZyEI48an-_No8W5017XeL5Z__kbwFpdpfcCZkknXSq3yA3qvoe2Qi-2tI3AVD67X1y2EEU08ZR0y7PLsw2nc6_7m1TU1s6mc5pU8OF44M9Fmfv6IReoTvTbrLFM15US8NMwDB5QI5mH79P91k4S4GVUBEsGSRiOlNaOaVcZTn8qyukqwrrSqGk01xabWwkeFKkmbRCpSpxuNdbGQ4VUSweklENctskVHIeYV9cJAoJ1WEKVgBlSZWkBQIDSTMmYi3SvAxA43jexXnud880FBydhHJURB4UMSasv2vRAW38g_8DaqvnRZhsf6G5PM2D1-UxL1MjQAKZhEeNEoMvKLDGTKzJYj4mz1HXeTdz2jt7PgF5aI2r4Zi89BwIlVFjL86pWbVtfjA__g-mb4cDpteByTUgjtKE-Qd4J4TgGnBuDTjB4csBeRMtcy2VNr9yDbhzba3Xk1_0ZPxR7K-rq2YVeBKVpumYPOqMu5esUH7CHih6YPYD0Q8p9Y8zj1SeKcgeOX_898d6Qm5zHCrxE55bZLS8XFVPIdVbFs-8P_8CyNxOQQ
  priority: 102
  providerName: ProQuest
Title Effect of asthma, COPD, and ACO on COVID-19: A systematic review and meta-analysis
URI https://www.ncbi.nlm.nih.gov/pubmed/36318528
https://www.proquest.com/docview/2731034554
https://www.proquest.com/docview/2731056888
https://pubmed.ncbi.nlm.nih.gov/PMC9624422
https://doaj.org/article/12c8a3c759444005a0325328995da912
http://dx.doi.org/10.1371/journal.pone.0276774
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhat1EMQgKkpUocx06QEOq6lg2JdSp06lvkfG1IXdI1rQQv_O3cOW4gqGi8-CE-5-Pns30X-35HyCvbThJpR74Fa5tnceU5lgpUZoEtYrM4EomT6dMW5-J0wj9NvekWWedsNQCWG107zCc1Wcy6329_fIAB_15nbZDOulF3XuRpF9wsASbNNtmBtUliToPPvN5XgNGtdy_RarEEs10TTPevuzQWK83pX8_crfmsKDeZpX-frvxjuRo-IPeNnUl7lWLskq00f0h2zUgu6RtDN_32ERlXBMa0yKgql9c36oj2RxcnR1TlCe31R7TI4cLl2YnlBO9oj_7mfqZV3IsWvEmXylKG4eQxmQwHX_unlsm0YMXgLywtMNNkIKTIhMjShMFTs4hnaZRksSt4JhlPpEpsl3mRH_DEFb7wMtwJThUDf8lxn5BWDrjtEcoZs_HUnO1GHHxHH3QEnJbU8yOkDeKqTdw1pGFsaMgxG8Ys1HtrEtyRCqEQOyI0HdEmVt1qXtFw3CF_jL1VyyKJtr5QLK5CMyZDh8W-cgGBgMOr2p7CD3TRA_USFTisTZ5jX4dVRGo9FYQ9wENKnCvb5KWWQCKNHE_qXKlVWYZno8v_EPoybgi9NkJZAXDEykRHwDchQVdD8rAhCdNB3KjeQ81co1KGYJ86tsvBbISWa23dXP2irsab4um7PC1WRsYTvu-3ydNKuWtkXaHj76FGNtS-AX2zJv92rXnMAwG2JWP7d8J8QO4xjDrRIaCHpLVcrNJnYAsuow7ZllMJpd93sBx-7JCd48H5xbij_6509PDH8ufgFzAsXXo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGeYAXxPhaYTCDQIC0bInt2AkSQqWltGysaGzT3oLz4Q1pS8rSCvFP8TdylzgdQRPwstfcJUruzvcR3_1MyFPXTVPlxoEDsc13hPY9R4faOJCLuCyJZeqZqttiR472xYdD_3CJ_GxmYbCtsvGJlaNOiwT_kW9CmPVcLiD6vZl-c_DUKNxdbY7QqM1iK_vxHUq28vV4APp9xtjw3V5_5NhTBZwEcuOZAymJCqWSRkqTpcxkiYmFyeLUJFwKo5hIlU5dzvw4CEXKZSB9g7uemWZQG3gcnnuFXBUcIjlOpg_fN54ffIeUdjyPK2_TWsPGtMizDSj_pFKiFf6qUwIWsaAzPSnKixLdP_s1fwuAw5vkhs1caa82tWWylOW3yLL1DSV9YQGsX94muzUkMi0M1eXs-FSv0_7k02Cd6jylvf6EFjlcOBgPHC98RXv0HE2a1pM0FeNpNtOOtpgpd8j-pUj5LunkILcVQgVjLvbhuTwWUI0GYHVQBmV-ECMQkdBdwhuRRokFNsfzNU6iardOQYFTSyhCRURWEV3iLO6a1sAe_-B_i9pa8CIsd3WhODuK7CqPPJYEmoMEQgGv6voaP5BjTeunOvRYl6yhrqN6xnXhXKIeyEMp9L5d8qTiQGiOHHt_jvS8LKPx5OA_mD7vtpieWyZTgDgSbect4JsQ8qvFudriBAeTtMgraJmNVMrofCnCnY21Xkx-vCDjQ7GfL8-KueXxZRAEXXKvNu6FZLmsJvqBolpm3xJ9m5J_Pa6Q0UMJ2Spj9__-Wmvk2mjv43a0Pd7ZekCuMxxoqaZLV0lndjbPHkKaOYsfVWubki-X7Ux-AS4Di08
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9RAEN_gmRhfjPjFKcpqNGpCuXZ3u9uaGHPeeeHEAAEhvNXtx4IJtCe9i_Ff869zpt0Wa4j6wmtn2rQzs_PRnfktIc9dN02VGwcOxDbfEdr3HB1q40Au4rIklqlnqm6Lbbl5ID4e-UdL5GczC4NtlY1PrBx1WiT4j3wAYdZzuYDoNzC2LWJ3PHk3--bgCVK409ocp1GbyFb24zuUb-Xb6Rh0_YKxyYfPo03HnjDgJJAnzx1IT1QolTRSmixlJktMLEwWpybhUhjFRKp06nLmx0EoUi4D6RvcAc00gzrB4_Dca-S64irANRaM2vYS8CNS2lE9rryBtYyNWZFnG1AKSqVEJxRWJwa0caE3Oy3Ky5LeP3s3fwuGk9vkls1i6bA2u2WylOV3yLL1EyV9ZcGsX98lezU8Mi0M1eX85Eyv09HO7nid6jylw9EOLXK4cDgdO174hg7pBbI0radqKsazbK4dbfFT7pGDK5HyfdLLQW4rhArGXOzJc3ksoDINwAKhJMr8IEZQIqH7hDcijRILco5nbZxG1c6dgmKnllCEioisIvrEae-a1SAf_-B_j9pqeRGiu7pQnB9HdsVHHksCzUECoYBXdX2NH8ixvvVTHXqsT9ZQ11E979o6mmgI8lAKPXGfPKs4EKYjR4M_1ouyjKY7h__BtL_XYXppmUwB4ki0nb2Ab0L4rw7naocTnE3SIa-gZTZSKaOLZQl3NtZ6OflpS8aHYm9fnhULy-PLIAj65EFt3K1kuaym-4GiOmbfEX2Xkn89qVDSQwmZK2MP__5aa-QGuJHo03R76xG5yXC2pRo0XSW9-fkiewwZ5zx-Ui1tSr5ctS_5BXbIj1A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+asthma%2C+COPD%2C+and+ACO+on+COVID-19%3A+A+systematic+review+and+meta-analysis&rft.jtitle=PloS+one&rft.au=Uruma%2C+Yuka&rft.au=Fujikura%2C+Yuji&rft.au=Manabe%2C+Toshie&rft.au=Iikura%2C+Motoyasu&rft.date=2022-11-01&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=17&rft.issue=11&rft.spage=e0276774&rft_id=info:doi/10.1371%2Fjournal.pone.0276774&rft.externalDBID=n%2Fa&rft.externalDocID=A724770703
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon